[HTML][HTML] c-Met in pancreatic cancer stem cells: therapeutic implications
M Herreros-Villanueva… - World journal of …, 2012 - ncbi.nlm.nih.gov
Pancreatic cancer is the deadliest solid cancer and currently the fourth most frequent cause
of cancer-related deaths. Emerging evidence suggests that cancer stem cells (CSCs) play a …
of cancer-related deaths. Emerging evidence suggests that cancer stem cells (CSCs) play a …
Mesenchymal stromal cells alone or expressing interferon-β suppress pancreatic tumors in vivo, an effect countered by anti-inflammatory treatment
S Kidd, L Caldwell, M Dietrich, I Samudio, EL Spaeth… - …, 2010 - Taylor & Francis
Background aims. Because of the inflammatory nature and extensive stromal compartment
in pancreatic tumors, we investigated the role of mesenchymal stromal cells (MSC) to engraft …
in pancreatic tumors, we investigated the role of mesenchymal stromal cells (MSC) to engraft …
Targeting tumor stroma using engineered mesenchymal stem cells reduces the growth of pancreatic carcinoma
C Zischek, H Niess, I Ischenko, C Conrad… - Annals of …, 2009 - journals.lww.com
Objective: To analyze the efficacy of engineered mesenchymal stem cell based therapy
directed towards pancreatic tumor stroma. Summary Background Data: Mesenchymal stem …
directed towards pancreatic tumor stroma. Summary Background Data: Mesenchymal stem …
Targeting epithelial-mesenchymal transition for identification of inhibitors for pancreatic cancer cell invasion and tumor spheres formation
Background Pancreatic cancer has an enrichment of stem-like cancer cells (CSCs) that
contribute to chemoresistant tumors prone to metastasis and recurrence. Drug screening …
contribute to chemoresistant tumors prone to metastasis and recurrence. Drug screening …
Neutralizing murine TGFβR2 promotes a differentiated tumor cell phenotype and inhibits pancreatic cancer metastasis
Elevated levels of TGFβ are a negative prognostic indicator for patients diagnosed with
pancreatic cancer; as a result, the TGFβ pathway is an attractive target for therapy. However …
pancreatic cancer; as a result, the TGFβ pathway is an attractive target for therapy. However …
A multipronged approach to pancreatic cancer treatment
MV Apte, JS Wilson - Nature Reviews Gastroenterology & Hepatology, 2016 - nature.com
Research has highlighted the importance of the stroma in pancreatic cancer, in particular the
role of complex interactions between cancer and stromal cells. A new study describes a …
role of complex interactions between cancer and stromal cells. A new study describes a …
Efficient elimination of pancreatic cancer stem cells by hedgehog/GLI inhibitor GANT61 in combination with mTOR inhibition
Y Miyazaki, S Matsubara, Q Ding, K Tsukasa… - Molecular cancer, 2016 - Springer
Background Pancreatic cancer is one of the most lethal malignancies. The innovative
treatments are required and now the cancer stem cells (CSCs) are expected to be an …
treatments are required and now the cancer stem cells (CSCs) are expected to be an …
Invasion-metastasis by hepatocyte growth factor/c-Met signaling concomitant with induction of urokinase plasminogen activator in human pancreatic cancer: role as …
KH Lee, MS Hyun, JR Kim - Cancer Research and Treatment, 2003 - e-crt.org
PURPOSE: Increased expression of the hepatocytes growth factor (HGF) receptor (c-Met)
and urokinase type plasminogen activator (uPA) correlate with the development and …
and urokinase type plasminogen activator (uPA) correlate with the development and …
Pancreatic adenocarcinoma therapeutics targeting RTK and TGF beta receptor
HH Yang, JW Liu, JH Lee, HJ Harn… - International journal of …, 2021 - mdpi.com
Despite the improved overall survival rates in most cancers, pancreatic cancer remains one
of the deadliest cancers in this decade. The rigid microenvironment, which majorly …
of the deadliest cancers in this decade. The rigid microenvironment, which majorly …
[HTML][HTML] Tumor microenvironment in chemoresistance, metastasis and immunotherapy of pancreatic cancer
S Wang, Y Li, C Xing, C Ding, H Zhang… - American journal of …, 2020 - ncbi.nlm.nih.gov
Pancreatic cancer (PC) is a fatal disease with high malignancy and difficult for early
diagnosis. PC causes more than 400,000 patient deaths world widely and becomes the …
diagnosis. PC causes more than 400,000 patient deaths world widely and becomes the …